Your browser doesn't support javascript.
loading
MiR-421 Aggravates Neurotoxicity and Promotes Cell Death in Parkinson's Disease Models by Directly Targeting MEF2D.
Dong, Yaru; Xiong, Jing; Ji, Liya; Xue, Xiuyun.
Afiliación
  • Dong Y; Department of Neurology, Xi'an central hospital, No. 161 Xi Wu Road, Xi'an, 710000, Shaanxi, China.
  • Xiong J; Department of Neurology, Xi'an central hospital, No. 161 Xi Wu Road, Xi'an, 710000, Shaanxi, China.
  • Ji L; Department of Neurology, Xi'an central hospital, No. 161 Xi Wu Road, Xi'an, 710000, Shaanxi, China.
  • Xue X; Department of Neurology, Xi'an central hospital, No. 161 Xi Wu Road, Xi'an, 710000, Shaanxi, China. 94482627@qq.com.
Neurochem Res ; 46(2): 299-308, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33179210
Parkinson's disease (PD) is a severe neurodegenerative disease characterized by selective loss of dopaminergic neurons, which reduces quality of life of patients and poses a heavy burden to the society. The pathological mechanism of PD remains unclear, and increasing efforts are aimed to solve this problem. MiRNAs are a kind of small noncoding RNA regulating target gene expression. Previous studies have shown that dysregulation of miRNAs is involved in the development of PD. In the present study, we determined that miR-421 and MEF2D are increased and decreased, respectively, in a cellular model of PD. The data on the mechanism of action indicate that miR-421 directly binds to MEF2D mRNA and negatively regulates MEF2D expression. An increase in miR-421 disrupted the Bcl2/Bax system. Functional assays indicated that enhanced miR-421 promotes cell death by negative modulation of MEF2D expression. Inhibition of miR-421 or restoration of MEF2D protected neurons from neurotoxicity in cellular and animal models of PD. Our study is the first to demonstrate that miR-421 is decreased in PD models and to determine a novel putative mechanism of PD pathogenesis.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Secundaria / Muerte Celular / Síndromes de Neurotoxicidad / MicroARNs Tipo de estudio: Prognostic_studies Aspecto: Patient_preference Límite: Animals Idioma: En Revista: Neurochem Res Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Secundaria / Muerte Celular / Síndromes de Neurotoxicidad / MicroARNs Tipo de estudio: Prognostic_studies Aspecto: Patient_preference Límite: Animals Idioma: En Revista: Neurochem Res Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos